EBRD Provides EUR 25 Million Investment Support to Orzax

Orzax, Turkey's market leader in dietary supplements, has signed a EUR 25 million credit agreement with the European Bank for Reconstruction and Development (EBRD) as part of its global growth targets. This financing will be used to establish the company's new production and logistics hub in Kazakhstan.

The facility, scheduled to become operational by the end of 2027, is positioned to serve as a logistics and strategic centre across a broad region spanning from Asia to Eastern Europe. This investment, which will leverage the free trade advantages offered by Kazakhstan, will transform the region into a global export hub.

Selman Alimoğlu: "This Trust in Orzax's Quality and Future"
Selman Alimoğlu, Chairman of Alyors Group, emphasised that this partnership with EBRD represents global confidence in Orzax's long-term vision:

"We are currently exporting to more than 50 countries. We are crowning our leadership in Turkey with this first overseas investment in Kazakhstan. The EUR 25 million support we have received from EBRD is the international recognition of Orzax's high quality standards and R&D vision. We will not only produce safe and certified dietary supplements, but also create a sustainable value chain by combining our global knowledge with local expertise. This impact, stretching from Central Asia to the world, will be the strongest building block of our growth strategy."

Health Standards for the Future Taking Shape with Orzax
This project will provide direct access to the Central Asian, Chinese, Caucasus and Southeast Asian markets. With its new production centre equipped with modern technologies, Orzax will continue to deliver the fastest and most reliable solutions to the growing global demand for healthy living. Turkey's leading brand is now stronger, bolder and more global on its path to becoming "the World's Health Partner".